BACKGROUND: CXCR3-associated chemokines CXCL9-CXCL11 promote histologic progression in chronic hepatitis C virus (HCV) infection, as indicated by elevated intrahepatic levels of messenger RNA in patients with advanced inflammation and fibrosis. We evaluated the potential of peripheral chemokine levels to discriminate among patients with chronic HCV infection who had different stages of fibrosis. METHODS: Peripheral levels of CXCR3-associated chemokines were measured by enzyme-linked immunosorbent assay of plasma samples obtained from 93 patients with chronic HCV infection. Of the subjects, 79 (85%) were white, and 68 (73%) were infected with HCV genotype 1. RESULTS: Expression of all 3 chemokines, when analyzed as a group, was significantly associated with intrahepatic inflammation and fibrosis. Plasma levels of CXCL10 were significantly elevated in patients with advanced fibrosis, whereas CXCL9 levels were significantly elevated in patients with advanced inflammation. By proportional odds multivariate modeling, we observed an association between fibrosis and CXCL10 (P< .002) as well as between fibrosis and inflammation (P<.001). Of the individual parameters, the CXCL10 level was most useful in identifying patients with more-severe (stage 3-4) fibrosis. Discriminatory ability was improved by the combination of CXCL10 and CXCL9. CONCLUSIONS: The strong association between CXCR3-associated chemokines and fibrosis suggests that they may have promise as noninvasive markers of hepatic fibrosis in a predominantly white HCV genotype 1-infected population.
BACKGROUND:CXCR3-associated chemokines CXCL9-CXCL11 promote histologic progression in chronic hepatitis C virus (HCV) infection, as indicated by elevated intrahepatic levels of messenger RNA in patients with advanced inflammation and fibrosis. We evaluated the potential of peripheral chemokine levels to discriminate among patients with chronic HCV infection who had different stages of fibrosis. METHODS: Peripheral levels of CXCR3-associated chemokines were measured by enzyme-linked immunosorbent assay of plasma samples obtained from 93 patients with chronic HCV infection. Of the subjects, 79 (85%) were white, and 68 (73%) were infected with HCV genotype 1. RESULTS: Expression of all 3 chemokines, when analyzed as a group, was significantly associated with intrahepatic inflammation and fibrosis. Plasma levels of CXCL10 were significantly elevated in patients with advanced fibrosis, whereas CXCL9 levels were significantly elevated in patients with advanced inflammation. By proportional odds multivariate modeling, we observed an association between fibrosis and CXCL10 (P< .002) as well as between fibrosis and inflammation (P<.001). Of the individual parameters, the CXCL10 level was most useful in identifying patients with more-severe (stage 3-4) fibrosis. Discriminatory ability was improved by the combination of CXCL10 and CXCL9. CONCLUSIONS: The strong association between CXCR3-associated chemokines and fibrosis suggests that they may have promise as noninvasive markers of hepatic fibrosis in a predominantly white HCV genotype 1-infected population.
Authors: Suganya Selvarajah; Sheila Keating; John Heitman; Kai Lu; Graham Simmons; Philip J Norris; Eva Operskalski; James W Mosley; Michael P Busch Journal: J Gen Virol Date: 2012-04-25 Impact factor: 3.891
Authors: Patrizia Farci; Kurt Wollenberg; Giacomo Diaz; Ronald E Engle; Maria Eliana Lai; Paul Klenerman; Robert H Purcell; Oliver G Pybus; Harvey J Alter Journal: Proc Natl Acad Sci U S A Date: 2012-07-24 Impact factor: 11.205
Authors: Jennifer C Lin; François Habersetzer; Maribel Rodriguez-Torres; Nezam Afdhal; Eric J Lawitz; Matthew S Paulson; Yanni Zhu; Gangadharan Mani Subramanian; John G McHutchison; Mark Sulkowski; David L Wyles; Robert T Schooley Journal: J Infect Dis Date: 2014-06-06 Impact factor: 5.226
Authors: E S Andersen; M Ruhwald; B Moessner; P B Christensen; O Andersen; J Eugen-Olsen; N Weis Journal: Eur J Clin Microbiol Infect Dis Date: 2011-01-13 Impact factor: 3.267
Authors: Marija Zeremski; Giles Hooker; Marla A Shu; Emily Winkelstein; Queenie Brown; Don C Des Jarlais; Leslie H Tobler; Barbara Rehermann; Michael P Busch; Brian R Edlin; Andrew H Talal Journal: J Hepatol Date: 2011-01-21 Impact factor: 25.083
Authors: Yedidya Saiman; JingJing Jiao; M Isabel Fiel; Scott L Friedman; Costica Aloman; Meena B Bansal Journal: Hepatol Res Date: 2014-10-07 Impact factor: 4.288